NVDA vs POWI

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

POWI exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a near-zero debt-to-equity ratio (0.03), indicating a fortress balance sheet. However, the stock is severely overvalued relative to deterministic baselines, trading at $56.05 against a Graham Number of $10.33 and an Intrinsic Value of $11.51. While forward P/E (30.44) suggests a recovery in earnings power, the current dividend payout ratio of 215.38% is unsustainable. The divergence between strong internal health and poor valuation/insider sentiment results in a neutral outlook.